| Jul 31 |
Is Teva Pharmaceutical Industries (TEVA) Stock Undervalued Right Now?
|
| Jul 31 |
Teva Pharma Flirts With Breakout As Generic Drugs Drive Beat-And-Raise
|
| Jul 31 |
Teva gains after lifting outlook on YTD performance
|
| Jul 31 |
Teva Pharmaceutical beats Q2 estimates, raises outlook
|
| Jul 31 |
Teva Announces Strong Growth in Second Quarter Revenues mainly driven by Generics Products in All Regions and AUSTEDO®; Raises 2024 Financial Guidance
|
| Jul 30 |
Teva Pharmaceutical Q2 2024 Earnings Preview
|
| Jul 29 |
Hospital Business Recovery to Aid Haemonetics' (HAE) Q1 Earnings
|
| Jul 29 |
Unveiling Teva Pharmaceutical Industries (TEVA) Q2 Outlook: Wall Street Estimates for Key Metrics
|
| Jul 29 |
Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings
|
| Jul 26 |
Teva's Q2 Outlook: Key Developments In Biosimilars And Pipeline Drugs
|
